Becton, Dickinson and Company (0R19.L)
USD 200.08
(-0.29%)
USD 200.08
(-0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.27 Billion USD | 9.21% |
| 2022 | 4.28 Billion USD | -2.33% |
| 2021 | 4.25 Billion USD | 26.72% |
| 2020 | 2.97 Billion USD | -18.28% |
| 2019 | 3.36 Billion USD | 11.16% |
| 2018 | 3.73 Billion USD | 32.05% |
| 2017 | 2.43 Billion USD | -3.12% |
| 2016 | 3.2 Billion USD | 19.52% |
| 2015 | 1.94 Billion USD | 24.66% |
| 2014 | 2.15 Billion USD | 1.27% |
| 2013 | 1.75 Billion USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.07 Billion USD | 41.11% |
| 2024 Q3 | 1.32 Billion USD | -5.5% |
| 2024 Q2 | 1.4 Billion USD | 31.58% |
| 2023 Q3 | 1.18 Billion USD | -5.11% |
| 2023 Q2 | 1.25 Billion USD | 4.59% |
| 2023 FY | - USD | -5.57% |
| 2023 Q1 | 1.19 Billion USD | 17.58% |
| 2023 Q4 | 946 Million USD | -20.37% |
| 2022 FY | - USD | -2.33% |
| 2022 Q4 | 1.01 Billion USD | -10.47% |
| 2022 Q3 | 1.13 Billion USD | -11.66% |
| 2022 Q2 | 1.28 Billion USD | -9.87% |
| 2022 Q1 | 1.42 Billion USD | 21.53% |
| 2021 Q1 | 1.88 Billion USD | 21.05% |
| 2021 Q3 | 1.14 Billion USD | 14.12% |
| 2021 FY | - USD | 26.72% |
| 2021 Q4 | 1.17 Billion USD | 2.35% |
| 2021 Q2 | 1 Billion USD | -46.66% |
| 2020 Q3 | 969 Million USD | -20.83% |
| 2020 Q4 | 1.55 Billion USD | 60.78% |
| 2020 FY | - USD | -18.28% |
| 2020 Q2 | 1.22 Billion USD | 9.09% |
| 2020 Q1 | 1.12 Billion USD | -22.41% |
| 2019 Q2 | 1.19 Billion USD | -0.66% |
| 2019 FY | - USD | 11.16% |
| 2019 Q4 | 1.44 Billion USD | 9.38% |
| 2019 Q3 | 1.32 Billion USD | 10.26% |
| 2019 Q1 | 1.2 Billion USD | -8.97% |
| 2018 FY | - USD | 32.05% |
| 2018 Q4 | 1.32 Billion USD | 3.67% |
| 2018 Q3 | 1.27 Billion USD | 1.03% |
| 2018 Q2 | 1.26 Billion USD | 44.19% |
| 2018 Q1 | 878 Million USD | 3.66% |
| 2017 Q4 | 847 Million USD | -3.42% |
| 2017 FY | - USD | -3.12% |
| 2017 Q1 | 823 Million USD | 6.06% |
| 2017 Q2 | 782 Million USD | -4.98% |
| 2017 Q3 | 877 Million USD | 12.15% |
| 2016 Q2 | 849 Million USD | 11.42% |
| 2016 Q3 | 884 Million USD | 4.12% |
| 2016 Q1 | 762 Million USD | 3.11% |
| 2016 Q4 | 776 Million USD | -12.22% |
| 2016 FY | - USD | 19.52% |
| 2015 Q2 | 544 Million USD | 4.02% |
| 2015 Q1 | 523 Million USD | -0.38% |
| 2015 FY | - USD | 24.66% |
| 2015 Q4 | 739 Million USD | -10.42% |
| 2015 Q3 | 825 Million USD | 51.65% |
| 2014 Q3 | 587 Million USD | 10.55% |
| 2014 Q2 | 531 Million USD | 2.12% |
| 2014 Q1 | 520 Million USD | -1.14% |
| 2014 FY | - USD | 1.27% |
| 2014 Q4 | 525 Million USD | -10.56% |
| 2013 Q2 | 517 Million USD | -0.77% |
| 2013 Q1 | 521 Million USD | 0.0% |
| 2013 Q4 | 526 Million USD | -7.07% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | 566 Million USD | 9.48% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 4252.703% |
| Accuray Incorporated | 9 Million USD | -47352.547% |
| Align Technology, Inc. | 799.03 Million USD | -435.018% |
| Elevance Health Inc. | 10.49 Billion USD | 59.247% |
| AxoGen, Inc. | -13.32 Million USD | 32175.33% |
| Boston Scientific Corporation | 3.61 Billion USD | -18.323% |
| CVS Health Corporation | 18.17 Billion USD | 76.483% |
| Cardinal Health, Inc. | 1.97 Billion USD | -116.127% |
| Centene Corporation | -463 Million USD | 1023.326% |
| DaVita Inc. | 2.34 Billion USD | -82.19% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 66.394% |
| Hologic, Inc. | 1.29 Billion USD | -229.81% |
| Humana Inc. | -561 Million USD | 862.032% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -251.082% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -216.807% |
| Masimo Corporation | 236.7 Million USD | -1706.084% |
| McKesson Corporation | 4.66 Billion USD | 8.399% |
| Patterson Companies, Inc. | 374.75 Million USD | -1040.742% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -146.824% |
| ResMed Inc. | 1.6 Billion USD | -167.132% |
| Henry Schein, Inc. | 943 Million USD | -353.34% |
| Teladoc Health, Inc. | 153.99 Million USD | -2676.028% |
| Universal Health Services, Inc. | 1.74 Billion USD | -145.207% |
| Veeva Systems Inc. | 429.33 Million USD | -895.728% |
| Baxter International Inc. | 2.77 Billion USD | -53.999% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -78.564% |
| Danaher Corporation | 7.49 Billion USD | 42.992% |
| Stryker Corporation | 5.16 Billion USD | 17.151% |
| Medtronic plc | 9.05 Billion USD | 52.794% |